Published in Am J Med on June 09, 2012
Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol (2013) 2.17
Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research. Arthritis Care Res (Hoboken) (2014) 0.92
What Strategies Do Physicians and Patients Discuss to Reduce Out-of-Pocket Costs? Analysis of Cost-Saving Strategies in 1,755 Outpatient Clinic Visits. Med Decis Making (2016) 0.80
[The first biologic for rheumatoid arthritis: factors influencing the therapeutic decision]. Z Rheumatol (2017) 0.78
Biologics Prescribing for Rheumatoid Arthritis in Older Patients: A Single-Center Retrospective Cross-Sectional Study. Rheumatol Ther (2015) 0.77
Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis. Am Health Drug Benefits (2017) 0.75
Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009. Perm J (2015) 0.75
A profile of the Medicare Current Beneficiary Survey. Health Care Financ Rev (1994) 11.74
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum (2008) 9.94
An epidemiology of disability among adults in the United States. Milbank Mem Fund Q Health Soc (1976) 8.76
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum (2004) 6.22
Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum (1997) 2.93
Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol (2003) 2.72
Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997. Arthritis Rheum (2007) 2.27
Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum (2007) 2.18
The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff (Millwood) (2009) 1.95
Reporting of drug expenditures in the MCBS. Health Care Financ Rev (2003) 1.79
Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population. Rheumatology (Oxford) (2008) 1.59
Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis (2006) 1.59
Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy. Bull NYU Hosp Jt Dis (2008) 1.48
Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis. Arthritis Rheum (2009) 1.28
Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study. J Rheumatol (2009) 1.28
Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res (2010) 1.27
Patterns of drug use in rheumatoid arthritis. J Rheumatol (2000) 1.16
Impact of Medicare Part D on seniors' out-of-pocket expenditures on medications. Arch Intern Med (2010) 1.16
Are rheumatologists' treatment decisions influenced by patients' age? Rheumatology (Oxford) (2006) 1.15
Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study. Arthritis Rheum (2007) 1.13
Safety of low dose methotrexate in elderly patients with rheumatoid arthritis. Postgrad Med J (2000) 1.12
Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient? Ann Rheum Dis (1993) 1.08
Missed opportunities in the treatment of elderly patients with rheumatoid arthritis. Rheumatology (Oxford) (2009) 1.01
Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics. Ann Rheum Dis (2005) 0.99
Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis. J Rheumatol (2003) 0.98
Trends in out-of-pocket medical care expenditures for Medicare-age adults with arthritis between 1998 and 2004. Arthritis Rheum (2008) 0.89
Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safety. Drugs Aging (2009) 0.86
Disease-modifying antirheumatic drugs. Potential effects in older patients. Drugs Aging (1995) 0.82
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97
MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol (2013) 112.81
MEGA-CC: computing core of molecular evolutionary genetics analysis program for automated and iterative data analysis. Bioinformatics (2012) 13.09
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA (2004) 5.25
Prescription drug use in pregnancy. Am J Obstet Gynecol (2004) 4.92
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA (2008) 4.74
Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med (2007) 3.71
Health plan members' views about disclosure of medical errors. Ann Intern Med (2004) 3.69
Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med (2007) 3.34
Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA (2006) 3.20
Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med (2008) 3.06
Propoxyphene use by community-dwelling and institutionalized elderly Medicare beneficiaries. J Am Geriatr Soc (2003) 2.69
Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med (2010) 2.51
The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med (2008) 2.46
Reader's guide to critical appraisal of cohort studies: 1. Role and design. BMJ (2005) 2.43
Variation in nursing home antipsychotic prescribing rates. Arch Intern Med (2007) 2.30
Exploring racial and ethnic disparities in prescription drug spending and use among Medicare beneficiaries. Am J Geriatr Pharmacother (2006) 2.29
Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med (2007) 2.27
Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med (2003) 2.19
Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol (2013) 2.17
A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf (2012) 2.11
Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc (2004) 2.08
The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes (2008) 2.03
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Medication errors among adults and children with cancer in the outpatient setting. J Clin Oncol (2008) 2.00
A critical review of methods to evaluate the impact of FDA regulatory actions. Pharmacoepidemiol Drug Saf (2013) 2.00
Prescribers' responses to alerts during medication ordering in the long term care setting. J Am Med Inform Assoc (2006) 1.92
Comparison of review articles published in peer-reviewed and throwaway journals. JAMA (2002) 1.89
Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med (2004) 1.86
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes. Arch Intern Med (2010) 1.86
A systematic review of validated methods for identifying heart failure using administrative data. Pharmacoepidemiol Drug Saf (2012) 1.86
Validation of a surveillance case definition for arthritis. J Rheumatol (2005) 1.85
Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ (2005) 1.84
FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf (2006) 1.83
Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit. Health Aff (Millwood) (2005) 1.80
Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer (2007) 1.71
Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: cause for concern in the old-old. Arch Intern Med (2002) 1.70
The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care (2005) 1.68
Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc (2004) 1.68
Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care (2004) 1.66
Atypical antipsychotics and parkinsonism. Arch Intern Med (2005) 1.66
Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc (2004) 1.63
Clinical application of a computerized system for physician order entry with clinical decision support to prevent adverse drug events in long-term care. CMAJ (2006) 1.59
A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med (2003) 1.58
National estimates of medication use in nursing homes: findings from the 1997 medicare current beneficiary survey and the 1996 medical expenditure survey. J Am Geriatr Soc (2005) 1.58
Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med (2004) 1.57
The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf (2012) 1.56
Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med (2002) 1.54
A demonstration of the impact of response bias on the results of patient satisfaction surveys. Health Serv Res (2002) 1.52
Patterns and predictors of mammography utilization among breast cancer survivors. Cancer (2006) 1.52
Pain management in nursing home residents with cancer. J Am Geriatr Soc (2015) 1.49
Communicating with patients about medical errors: a review of the literature. Arch Intern Med (2004) 1.48
Challenges of estimating health service utilization for osteoarthritis patients on a population level. J Rheumatol (2002) 1.48
Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007. JAMA (2009) 1.48
Can pay-for-performance take nursing home care to the next level? J Am Geriatr Soc (2008) 1.45
Chronic disease score as a predictor of hospitalization. Epidemiology (2002) 1.43
Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc (2011) 1.43
Did Medicare Part D Affect National Trends in Health Outcomes or Hospitalizations? A Time-Series Analysis. Ann Intern Med (2015) 1.42
Computerized physician order entry with clinical decision support in the long-term care setting: insights from the Baycrest Centre for Geriatric Care. J Am Geriatr Soc (2005) 1.41
Trends in prehospital delay in patients with acute myocardial infarction (from the Worcester Heart Attack Study). Am J Cardiol (2008) 1.36
Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf (2007) 1.35
Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther (2009) 1.35
Creating a research data network for cardiovascular disease: the CVRN. Expert Rev Cardiovasc Ther (2008) 1.32
Twenty-year trends in the incidence of stroke complicating acute myocardial infarction: Worcester Heart Attack Study. Arch Intern Med (2008) 1.32
Reported racial discrimination, trust in physicians, and medication adherence among inner-city African Americans with hypertension. Am J Public Health (2013) 1.29
Medical abbreviations: writing little and communicating less. Arch Dis Child (2008) 1.28
Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc (2007) 1.28
Gender and risk of adverse outcomes in heart failure. Am J Cardiol (2004) 1.26
Exclusion of older adults and women from recent trials of acute coronary syndromes. J Am Geriatr Soc (2011) 1.23
Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc (2005) 1.22
Disclosure of medical errors: what factors influence how patients respond? J Gen Intern Med (2006) 1.21
Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007. Med Care (2011) 1.21
Medication discrepancies upon hospital to skilled nursing facility transitions. J Gen Intern Med (2009) 1.20
Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol (2002) 1.19
Medicare beneficiaries and free prescription drug samples: a national survey. J Gen Intern Med (2008) 1.18
Nurse-physician communication in the long-term care setting: perceived barriers and impact on patient safety. J Patient Saf (2009) 1.16
Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch Intern Med (2008) 1.16
Patients' knowledge and beliefs concerning gout and its treatment: a population based study. BMC Musculoskelet Disord (2012) 1.15
Computerized clinical decision support during medication ordering for long-term care residents with renal insufficiency. J Am Med Inform Assoc (2009) 1.14
Nursing home residents and enrollment in Medicare Part D. J Am Geriatr Soc (2009) 1.14
Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. Am J Manag Care (2006) 1.14
Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis. J Clin Epidemiol (2005) 1.13
Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc (2013) 1.12
Pay-for-performance in nursing homes. Health Care Financ Rev (2009) 1.11
Medication errors in the homes of children with chronic conditions. Arch Dis Child (2011) 1.11
Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program. Pharmacoepidemiol Drug Saf (2012) 1.10
Do-not-resuscitate orders in patients hospitalized with acute myocardial infarction: the Worcester Heart Attack Study. Arch Intern Med (2004) 1.10
Computerized physician order entry with clinical decision support in long-term care facilities: costs and benefits to stakeholders. J Am Geriatr Soc (2007) 1.10
Drug shortages and clinicians: no time for complacency. Arch Intern Med (2012) 1.09
Antipsychotic use among nursing home residents. JAMA (2013) 1.09
Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions. Am J Med (2010) 1.07